Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. 1998

S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
Department of Immunology, Novartis Research Institute, Vienna, Austria.

The expression of human immunodeficiency virus type 1 (HIV-1) structural proteins requires the action of the viral trans-regulatory protein Rev. Rev is a nuclear shuttle protein that directly binds to its cis-acting Rev response element (RRE) RNA target sequence. Subsequent oligomerization of Rev monomers on the RRE and interaction of Rev with a cellular cofactor(s) result in the cytoplasmic accumulation of RRE-containing viral mRNAs. Moreover, Rev by itself is exported from the nucleus to the cytoplasm. Although it has been demonstrated that Rev multimerization is critically required for Rev activity and hence for HIV-1 replication, the number of Rev monomers required to form a trans-activation-competent complex on the RRE is unknown. Here we report a systematic analysis of the putative multimerization domains within the Rev trans-activator protein. We identify the amino acid residues which are part of the proposed single hydrophobic surface patch in the Rev amino terminus that mediates intermolecular interactions. Furthermore, we show that the expression of a multimerization-deficient Rev mutant blocks HIV-1 replication in a trans-dominant (dominant-negative) fashion.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D015694 Gene Products, rev Trans-acting nuclear proteins whose functional expression are required for retroviral replication. Specifically, the rev gene products are required for processing and translation of the gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (CAR) in env, also known as the rev-responsive element (RRE), is responsive to the rev gene product. Rev is short for regulator of virion. rev Gene Products,rev Protein,Gene Product, rev,rev Gene Product

Related Publications

S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
January 1991, Journal of virology,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
May 2005, The Journal of general virology,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
June 1994, Journal of virology,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
June 1993, European journal of biochemistry,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
July 1991, Journal of virology,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
August 1990, Journal of virology,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
February 1990, Molecular and cellular probes,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
November 1989, DNA (Mary Ann Liebert, Inc.),
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
October 1990, Proceedings of the National Academy of Sciences of the United States of America,
S L Thomas, and M Oft, and H Jaksche, and G Casari, and P Heger, and M Dobrovnik, and D Bevec, and J Hauber
February 1996, Journal of virology,
Copied contents to your clipboard!